English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 10 Help

Selected(0)Clear Items/Page:    Sort:
Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population Journal article
Qin, Zixin, Li, Jiaheng, Tam, Benjamin, Sinha, Siddharth, Zhao, Bojin, Bhaskaran, Shanmuga Priya, Huang, Teng, Wu, Xiaobing, Chian, Jia Sheng, Guo, Maoni, Kou, Si Hoi, Lei, Huijun, Zhang, Li, Wang, Xiaoyu, Lagniton, Philip Naderev P., Xiao, Fengxia, Jiang, Xinyang, Wang, San Ming. Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population[J]. International Journal of Cancer, 2022, 152(6), 1159-1173.
Authors:  Qin, Zixin;  Li, Jiaheng;  Tam, Benjamin;  Sinha, Siddharth;  Zhao, Bojin; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:5.7/6.0 | Submit date：2023/01/30
Asian  Brca1  Brca2  Cancer  Database  Evolution  Germline Variation  Population  Structure  Variation  
Germline variation in BRCA1/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients Journal article
Bhaskaran,Shanmuga Priya, Chandratre,Khyati, Gupta,Hemant, Zhang,Li, Wang,Xiaoyu, Cui,Jian, Kim,Yeong C., Sinha,Siddharth, Jiang,Luhan, Lu,Boya, Wu,Xiaobing, Qin,Zixin, Huang,Teng, Wang,San Ming. Germline variation in BRCA1/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients[J]. International Journal of Cancer, 2019, 145(4), 962-973.
Authors:  Bhaskaran,Shanmuga Priya;  Chandratre,Khyati;  Gupta,Hemant;  Zhang,Li;  Wang,Xiaoyu; et al.
Favorite | TC[WOS]:55 TC[Scopus]:64  IF:5.7/6.0 | Submit date：2021/03/02
Brca1  Brca2  Breast Cancer  Chinese  Ethnic-specific  Mutation  Population  
Germline variation in BRCA1/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients Journal article
Wang, S. M.. Germline variation in BRCA1/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients[J]. International Journal of Cancer, 2019, 1-12.
Authors:  Wang, S. M.
Favorite | TC[WOS]:55 TC[Scopus]:64 | Submit date：2022/07/27
Reast Cancer  Brca1  Brca2  Ethnic-specific  Population  Mutation  Chinese  
An Example of using Precision Medicine in Cancer Care: Dynamic Change of TET2 Mutation in a Patient with Therapy-related Myelodysplastic Syndrome/ Acute Myeloid Leukemia Journal article
Chen, P, Kim, Y, Akhtari, M, Wang, S. M.. An Example of using Precision Medicine in Cancer Care: Dynamic Change of TET2 Mutation in a Patient with Therapy-related Myelodysplastic Syndrome/ Acute Myeloid Leukemia[J]. International Journal of Cancer Research and Molecular Mechanisms, 2017, 1-5.
Authors:  Chen, P;  Kim, Y;  Akhtari, M;  Wang, S. M.
Favorite |  | Submit date：2022/07/27
Exome sequencing  Somatic mutation  tMDS/AML  TET2  
An Example of using Precision Medicine in Cancer Care: Dynamic Change of TET2 Mutation in a Patient with Therapy-related Myelodysplastic Syndrome/Acute Myeloid Leukemia Journal article
Peixian Chen, Yeong C Kim, Mojitaba Akhtari, San Ming Wang. An Example of using Precision Medicine in Cancer Care: Dynamic Change of TET2 Mutation in a Patient with Therapy-related Myelodysplastic Syndrome/Acute Myeloid Leukemia[J]. International Journal of Cancer Research and Molecular Mechanisms, 2017, 3(2).
Authors:  Peixian Chen;  Yeong C Kim;  Mojitaba Akhtari;  San Ming Wang
Favorite | TC[Scopus]:0 | Submit date：2018/12/18
Exome Sequencing  Somatic Mutation  Tmds/aml  Tet2  
A dual‐specific anti‐IGF‐1/IGF‐2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma Journal article
Zhao, Q., Tran, H., Dimitrov, D., Cheung, N.. A dual‐specific anti‐IGF‐1/IGF‐2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma[J]. International Journal of Cancer, 2015, 2243-2252.
Authors:  Zhao, Q.;  Tran, H.;  Dimitrov, D.;  Cheung, N.
Favorite |   IF:5.7/6.0 | Submit date：2023/08/30
IGF-1  IGF-2  chemotherapy  neuroblastoma  temsirolimus  
A dual specific anti-IGF-1/IGF-2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma Journal article
Qi Zhao, Hoa Tran, Dimiter S. Dimitrov, Nai-Kong V. Cheung. A dual specific anti-IGF-1/IGF-2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma[J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137(9), 2243-2252.
Authors:  Qi Zhao;  Hoa Tran;  Dimiter S. Dimitrov;  Nai-Kong V. Cheung
Favorite | TC[WOS]:21 TC[Scopus]:21  IF:5.7/6.0 | Submit date：2019/01/23
Igf-1  Igf-2  Temsirolimus  Chemotherapy  Neuroblastoma  
A dual-specific anti-IGF-1/IGF-2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma Journal article
Zhao Q., Tran H., Dimitrov D.S., Cheung N.-K.V.. A dual-specific anti-IGF-1/IGF-2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma[J]. International Journal of Cancer, 2015, 137(9), 2243-2252.
Authors:  Zhao Q.;  Tran H.;  Dimitrov D.S.;  Cheung N.-K.V.
Favorite | TC[WOS]:21 TC[Scopus]:21 | Submit date：2019/01/16
Chemotherapy  Igf-1  Igf-2  Neuroblastoma  Temsirolimus  
Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism Journal article
Ma Z., Zhang T., Wang R., Cheng Z., Xu H., Li W., Wang Y., Wang X.. Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism[J]. International Journal of Gynecological Cancer, 2011, 21(4), 616-624.
Authors:  Ma Z.;  Zhang T.;  Wang R.;  Cheng Z.;  Xu H.; et al.
Favorite | TC[WOS]:19 TC[Scopus]:20 | Submit date：2019/01/16
Epithelial Ovarian Cancer  Metastasis  Monocytes  Tissue Factor-factor Vii  
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models Journal article
Sredni B., Xu R.-H., Albeck M., Gafter U., Gal R., Shani A., Tichler T., Shapira J., Bruderman I., Catane R., Kaufman B., Whisnant J.K., Mettinger K.L., Kalechman Y.. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models[J]. International Journal of Cancer, 1996, 65(1), 97-103.
Authors:  Sredni B.;  Xu R.-H.;  Albeck M.;  Gafter U.;  Gal R.; et al.
Favorite | TC[WOS]:68 TC[Scopus]:72  IF:5.7/6.0 | Submit date：2018/12/20